Drug
Ziconotide clinical trials
Also written Prialt.
How studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2002 (1)
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2014 | 1 |
| 2016 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 4
Elan Pharmaceuticals (2) · Albany Medical College (1) · University Hospital, Linkoeping (1) · Neurex (1) · National Cancer Institute, Naples (1) · Aaron Boster (1)
Related medicines
As reviewed, each with the page that says it.
- One of Analgesics, Non-Narcotic source
- One of Calcium Channel Blockers source
- One of Neuroprotective Agents source
Studies
Open first, then newest update. How each study uses ziconotide is read from its arms, and is right about nine times in ten.
Testing it · 7
- Safety and Activity Study of Intrathecally Administered Ziconotide for Neuropathic Pain in Patients With CancerStatus unknownPhase 2National Cancer Institute, NaplesNCT00996983Written as ziconotide
- Ziconotide as First-Line IDTCompletedPhase 4Albany Medical CollegeNCT03321955Written as Ziconotide 100 MCG(microgram)/ML Intrathecal Solution
- Single Shot Intrathecal Ziconotide for Painful Neuropathy or MyelopathyWithdrawnPhase 4Aaron BosterNCT01992562Written as Ziconotide
- Ziconotide Effectiveness and Safety Trial in Patients With Chronic Severe PainCompletedPhase 3Elan PharmaceuticalsNCT00076544Written as Ziconotide
- Prialt (Ziconotide) In Severe Chronic PainCompletedPhase 3Elan PharmaceuticalsNCT00047749Written as Prialt (ziconotide)
- Intrathecal Bolus Doses of ZiconotideCompletedPhase 4University Hospital, LinkoepingNCT01373983Written as Ziconotide
- A Multicenter Phase II/III, Placebo-Controlled Study of SNX-111 Administered Intrathecally to Cancer and AIDS Patients With Chronic PainCompletedPhase 2NeurexNCT00002160Written as Ziconotide
Codes
What other systems call ziconotide · ClinicalTrials.gg INT003685
- MeSH (NLM) C078452ziconotideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 7I64C51O16ZICONOTIDEConfirmed FDA, NLM, Wikidata
- RxNorm 68503Confirmed FDA, Wikidata
- Wikidata Q198473ziconotideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1475ZiconotideConfirmed FDA, Wikidata
- DrugBank DB06283One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C078452 | ziconotide | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 7I64C51O16 | ZICONOTIDE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 68503 | — | Confirmed FDA, Wikidata |
| Wikidata | Q198473 | ziconotide | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1475 | Ziconotide | Confirmed FDA, Wikidata |
| DrugBank | DB06283 | — | One source Wikidata |
Also registered as leconotide (UNII 2P1P5JB93S) and ziconotide acetate (UNII T2I226K69M · RxNorm 486126).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.